January 16, 2025

Now Enrolling: This lung cancer patient registry study by PrECOG aims to better understand an FDA-approved treatment

This registry study is collecting real-world data on patients with advanced, EGFR-positive non-small cell lung cancer who may not have had the opportunity, wanted to, or been eligible to enroll in a trial